New 2021 Forecasts Released

New Data
innovation hub

Oncodigm BioPharma (NASDAQ: ONTY) (TSX: ONY) is Profiled in this Database

Updated At 07 Dec, 2009

Start Free 7 Day Trial Now
Partial description of this company
Liposomal formulation of recombinant IL-2 for use as chemotherapy or cancer vaccine adjuvant

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of Oncodigm BioPharma (NASDAQ: ONTY) (TSX: ONY) plus 4809 other startups.

Start Free 7 Day Trial Now

Learn More About Oncodigm BioPharma (NASDAQ: ONTY) (TSX: ONY)

Technology/product details

More

Our Clients